EUVIMED · CrossrefZeitschrift
Seminars in Oncology
ISSN 0093-7754 · Elsevier BV
Neueste Artikel
Immunotherapy in multiple myeloma: Molecular mechanisms, current clinical strategies, resistance, and future perspectives
Mutation-associated cGAS-STING signaling and the co-evolution of the tumor immune microenvironment in DNA damage repair-deficient tumors: from spatial architecture to bedside translation
Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma
The Frozen Section Debate in Head and Neck Cancer: Evidence, Limitations, and Future Directions
Plasma lipid species and breast cancer phenotypes: a two-sample Mendelian randomization analysis with multiplicity and sensitivity assessment
No Recurrent Severe Immune-Related Hepatitis During PD-L1 Therapy After PD-1-Related Hepatitis in Advanced Gastroesophageal Junction Adenocarcinoma: A Case Report
Cancer-associated fibroblasts in bladder cancer: Immunosuppressive mechanisms and therapeutic targeting
Targeting TREM2+tumor-associated macrophages reactivates antitumor immunity and improves anti-PD-1 efficacy in gastric cancer
Machine learning-based integration develops a lactate metabolism related gene signature for improving outcomes in pancreatic ductal adenocarcinoma
Colchicine as an anti-inflammatory agent improving cancer prognosis: A therapeutic repurposing perspective
Purine metabolism in tumorigenesis and its clinical implications
Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer
Mapping the epidemiology of cancer-related anemia: A systematic scoping review of global prevalence and incidence
Artificial intelligence-driven intelligent nanocarriers for cancer theranostics: A paradigm shift with focus on brain tumors
Deciphering the prognostic value and immunotherapeutic strategy of aggrephagy in melanoma: Integrating single-cell sequencing and machine learning
Baicalein and baicalin in cancer therapy: Multifaceted mechanisms, preclinical evidence, and translational challenges
From tissue architecture to clinical insights: Spatial transcriptomics in solid tumor studies
Prostate cancer in Türkiye: Trend analysis of incidence and mortality rates
Metabolic reprogramming: The driving force behind cancer drug resistance
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer
Lactylation in radiosensitivity regulation: Mechanistic insights and recent advances
Deciphering autophagy signaling in cancer: A paradigm shift from molecular classifications to clinical innovations
The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment
Identifying and closing information gaps in head and neck cancer surgery
A 3-miRNA signature for noninvasive breast cancer detection
Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer
EUVIMED